These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 27524468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.
    Dubrall D, Schmid M, Stingl JC, Sachs B.
    PLoS One; 2020; 15(3):e0230632. PubMed ID: 32214375
    [Abstract] [Full Text] [Related]

  • 3. ACE inhibitor-mediated angioedema.
    Montinaro V, Cicardi M.
    Int Immunopharmacol; 2020 Jan; 78():106081. PubMed ID: 31835086
    [Abstract] [Full Text] [Related]

  • 4. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
    Maroteau C, Siddiqui MK, Veluchamy A, Carr F, White M, Cassidy AJ, Baranova EV, Rasmussen ER, Eriksson N, Bloch KM, Brown NJ, Bygum A, Hallberg P, Karawajczyk M, Magnusson PKE, Yue QY, Syvänen AC, von Buchwald C, Alfirevic A, Maitland-van der Zee AH, Wadelius M, Palmer CNA, PREDICTION-ADR.
    Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
    [Abstract] [Full Text] [Related]

  • 5. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
    Schlienger RG, Korn JR, Wehler E, Lopez Leon S, Yeaw J.
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):465-474. PubMed ID: 28779444
    [Abstract] [Full Text] [Related]

  • 6. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE, Nitsch D, Smeeth L, Bhaskaran K, Tomlinson LA.
    BMJ Open; 2016 Dec 21; 6(12):e012690. PubMed ID: 28003286
    [Abstract] [Full Text] [Related]

  • 7. A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA.
    Do TP, Seetasith A, Belleli R, Schlienger RG, Corda S, Burudpakdee C, Streefkerk HJ, Behr S.
    Am J Cardiovasc Drugs; 2018 Jun 21; 18(3):205-211. PubMed ID: 29177815
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study.
    Rasmussen ER, Pottegård A, Bygum A, von Buchwald C, Homøe P, Hallas J.
    J Intern Med; 2019 May 21; 285(5):553-561. PubMed ID: 30618189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S.
    Arch Intern Med; 2012 Nov 12; 172(20):1582-9. PubMed ID: 23147456
    [Abstract] [Full Text] [Related]

  • 13. Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
    Mahmoudpour SH, Asselbergs FW, Souverein PC, de Boer A, Maitland-van der Zee AH.
    Br J Clin Pharmacol; 2018 Oct 12; 84(10):2365-2372. PubMed ID: 29943849
    [Abstract] [Full Text] [Related]

  • 14. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
    Cardwell CR, Mc Menamin ÚC, Hicks BM, Hughes C, Cantwell MM, Murray LJ.
    BMC Med; 2014 Feb 13; 12():28. PubMed ID: 24521426
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors.
    Mahmoudpour SH, Asselbergs FW, de Keyser CE, Souverein PC, Hofman A, Stricker BH, de Boer A, Maitland-van der Zee AH.
    Int J Clin Pharm; 2015 Dec 13; 37(6):1095-103. PubMed ID: 26159317
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.